Stacie S Canan Koch

Title: **Stacie S Canan Koch: Innovator in Pharmaceutical Advancements**

Introduction

Stacie S Canan Koch is a prominent inventor based in San Diego, California, known for her significant contributions to the field of pharmaceuticals. With two patents to her name, she is celebrated for her innovations in the development of tricyclic retinoids, compounds instrumental in therapeutic applications.

Latest Patents

Her latest patents focus on "Tricyclic retinoids, methods for their production and use." These patents detail tricyclic retinoids that exhibit activity for retinoic acid receptors and/or retinoid X receptors. Stacie’s work not only centers on these unique compounds but also includes pharmaceutical compositions that integrate such tricyclic retinoid compounds and their methods for therapeutic use.

Career Highlights

Stacie is currently associated with Ligand Pharmaceuticals, Inc., where her expertise is applied towards developing innovative solutions in pharmaceutical sciences. Her work is characterized by a commitment to enhancing drug formulations and understanding the mechanisms of retinoid action in the body.

Collaborations

Throughout her career, Stacie has collaborated with esteemed colleagues, including Chan Kou Hwang and Steven K White. These partnerships contribute to a dynamic research environment that fosters innovative thinking and the advancement of new therapeutic methods.

Conclusion

Stacie S Canan Koch’s work exemplifies the spirit of innovation in the pharmaceutical industry. Her patents continue to pave the way for advancements in medicine, particularly through the application of tricyclic retinoids. With her commitment to research and development, she remains an influential figure in her field.